SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-004683
Filing Date
2022-01-24
Accepted
2022-01-24 20:05:36
Documents
1
Period of Report
2022-01-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4241
  Complete submission text file 0001209191-22-004683.txt   5718
Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EFFECTOR THERAPEUTICS 11120 ROSELLE STREET, SUITE A SAN DIEGO CA 92121
Business Address
Patel Premal (Reporting) CIK: 0001879012 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39866 | Film No.: 22550860